Stay updated on Nivolumab and Plinabulin in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Nivolumab and Plinabulin in NSCLC Clinical Trial page.

Latest updates to the Nivolumab and Plinabulin in NSCLC Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedRevision: v3.6.6 appears as the new page revision tag, replacing Revision: v3.6.5. This is a minor release update to the page and does not modify the displayed study details.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe page revision was updated from v3.6.4 to v3.6.5, indicating a minor update to the record display.SummaryDifference0.1%

- Check47 days agoChange DetectedThe page's revision tag was updated from v3.6.3 to v3.6.4, reflecting a minor update to the study record metadata.SummaryDifference0.1%

- Check69 days agoChange DetectedThe page revision was updated from v3.6.2 to v3.6.3. This appears to be a minor maintenance update that does not alter the study details or user-visible content.SummaryDifference0.1%

- Check76 days agoChange DetectedThe page's revision tag was updated from v3.6.0 to v3.6.2. This signals a backend/frontend maintenance update without altering the displayed study details.SummaryDifference0.1%

- Check91 days agoChange DetectedNew help and navigation items were added to the page: No longer looking for participants, How to Read a Study Record, Common Questions, How to Join a Study, and an updated Intervention/Treatment section label, while the older Intervention / Treatment label was removed. The revision badge changed from Revision: v3.5.5 to Revision: v3.6.0.SummaryDifference0.5%

Stay in the know with updates to Nivolumab and Plinabulin in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab and Plinabulin in NSCLC Clinical Trial page.